Scroll To Top

Generic name: daclatasvir

Daklinza

Maker:
Daklinza

What it does:
Treats chronic hepatitis C

Traditional dosage:
One 60 mg tablet taken orally, once daily in combination with sofosbuvir (Sovaldi) with or without ribavirin (Rebetol, Copegus, Virazole, Ribasphere). Also available in 30 mg and 90 mg doses.

Drug interactions, precautions, & recommendations:
Do not take with amiodarone, anticonvulsants (phenytoin, carbamazepine), antimycobacterials (rifampin), and St. John’s wort. Use caution with atorvastatin, fluvastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin. Dosage adjustments may been necessary when taken with protease inhibitors (atazanavir, ritonavirb, indinavir, nelfinavir, saquinavir), cobicistat-containing antiretroviral regimens, NNRTIs (efavirenzb, etravirine, nevirapine), clarithromycin, itraconazole, ketoconazole, nefazodone, posaconazole, telithromycin, voriconazole, bosentan, dexamethasone, modafinil, nafcillin, rifapentine, and digoxin.

The Federal Drug Administration issued the following label warning to be added to all hepatitis C (HCV) direct-acting antivirals (DAAs): Risk of hepatitis B virus (HBV) reactivation in patients connected with HCV and HBV has been reported, in some cases resulting in fulminant hepatitis, hepatic failure, and death.

Side effects:
Most serious: symptomatic bradycardia (in patients taking Solvaldi, Harvoni, or amiodarone: Cordarone, Nexterone, Pacerone)
Other: headache, fatigue

Advocate Channel - The Pride StoreOut / Advocate Magazine - Fellow Travelers & Jamie Lee Curtis

From our Sponsors

Most Popular

Latest Stories

HIV Plus Editors

Editor

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.